The GLP-1 RA monitoring report describes more detailed information about the overall population of patients being prescribed these medications (including demographics and comorbidities), and the proportion and characteristics of patients who filled a GLP-1 RA prescription over time using dispenses
A new Alzheimer's disease interventive strategy: GLP-1
Purchasers must be 21+ and qualified to handle research materials.
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, antioxidant, and neuroprotective propertiesthat position them as transformative candidates for ocular therapeutics
Stay calm, declare your medication first, and let the security officer do their job
It explored the mechanisms of action of GLP-1RAs and their therapeutic potential in a wide array of diseases, such as diabetes mellitus, providing new insights into metabolic disease management